Genetic Testing Company | The DNA Diagnostic Experts | GeneDx

In observance of the holidays, GeneDx will be closed for business on Thursday, December 25, 2014 and on Thursday, January 1, 2015. We will be unable to receive and process specimens. FedEx and UPS will also not be in operation. Except for the aforementioned dates, GeneDx will operate on our normal schedule (Monday-Saturday), including December 24th and December 31st.  If you have any questions or inquiries, please call us at 301-519-2100 or email us at zebras@genedx.com.

CYP1B1 Gene Sequencing

FORMS AND DOCUMENTS

TEST DETAILS

Genes:
CYP1B1
Disorders:
Clinical Utility:
  • Confirmation of a clinical diagnosis
  • Recurrence risk assessment
  • Prenatal diagnosis
Lab Method:
Capillary Sequencing

ORDERING

Test Code:
330
Turnaround Time:
5-6 weeks
Preferred Specimen:
2-5 mL Blood - Lavender Top Tube

BILLING

CPT Codes:
81404x1
New York Approved:
No
ABN Required:
Yes
Billing Information:
View Billing Policy
ICD Codes:
  • 365.14: Glaucoma of childhood, Infantile or juvenile glaucoma
  • 365.10: Open-angle glaucoma, unspecified, Wide-angle glaucoma NOS
  • 743.2: Buphthalmos Glaucoma: congenital newborn Hydrophthalmos
  • 365.41: Glaucoma associated with chamber angle anomalies
  • 365.11: Primary open angle glaucoma, Chronic simple glaucoma
  • 365.42: Glaucoma associated with anomalies of iris
  • 365.12: Low tension glaucoma
  • 365.43: Glaucoma associated with other anterior segment anomalies
* For price inquiries please email zebras@genedx.com

REFERENCES

  1. Aung T (2005) Invest Ophthalmol Vis Sci. 46(8):2816-22.
  2. Miyazawa et al., (2007) Molecular Vision 13: 1912-1919.
  3. Weisschuh et al., (2007) Molecular Vision 13:724-729.
  4. Hauser et al., (2006) ) Invest Opht and Vis Sci 47:2542-2546.
  5. Monemi et al., (2005) Hum Mol Genet 14;6: 725-733.
  6. Aung et al., (2005) ) Invest Opht and Vis Sci 46;8: 2816-2822.
  7. Kumar A (2007) Molecular Vision;13:667-676.
  8. Chavarria-Soley G., (2006) Glaucoma; 15(6):499- 504.
  9. B.J. Fan et al., (2006) Clinical Biochemistry 39 231–239.
  10. Stoilov IR., (2002) Invest Opht and Vis Sci;43:1820-1827.
  11. Bejjani BA et al (1998) Am J Hum Genet;62(2):325-33.
  12. Plasilova M., (1999) J Med Genet;36(4):290-4.
  13. Mashima Y., (2001) Invest Ophthalmol Vis Sci;42(10):2211-6.
  14. Rezaie et al. (2002) Science 295:1077-1079.

Back To Top